Borsa Italiana, suspension of the March 31, 2023 hearing

Borsa Italiana, suspension of the March 31, 2023 hearing

Preliminary March inflation numbers for Italy and Europe were better than the analyst consensus. The spotlight is always on the bankers

The main indices of the Italiana Stock Exchange and a record of the main European financial centers Fractional progression In the last session of the week. the Preliminary data on inflation for March in Italy and Europe It was better than the analyst consensus.

at 12.45 FTSEMib It rose by 0.46% to 27,146 points, after it oscillated between a low of 26,883 points and a high of 27,149 points. At the same time FTSE Italia All Share He earned 0.47%. plus sign for file Medium hat from FTSE Italia (+ 0.54%) and l Star of FTSE Italy (+0.11%).

the Bitcoins It is confirmed for less than $ 28,000 (about 25,500 euros).

the BTP-Bund spread narrowed to 180 points, with BTP return for ten years which decreased to less than 4.2%.

L’euro It fell below $1.09.

Always highlight titles The banking sector.

Minimum discount UniCredit (-0.08% to €17,446)On the day when the Institute’s shareholders meet to approve the 2022 budget.

worst performance for BancoBPM (-1.04%) f Bank Paper (-0.52%).

On the rise, however, the Monte dei Paschi di Siena (+ 1.42%).

Shy’s rebound Italian Post (+0.26%).

The decline is highlighted in the STAR sector Says Jetters (-7.42% to €29.95). In connection with the binding agreement regarding the sale of the Nitinol business to Esonetics, the Company announced that it has received a request for additional information from the Federal Trade Commission regarding the presumptive sale of Memry Corporation and SAES Smart Materials of the United States.

See also  Italian Stock Exchange, suspension from the session of September 25, 2023

worst performance for Giglio Group (-12.6% to €0.883). The company announced that it has approved the 2023-2027 business plan. Management has specified that the plan will be reviewed by a consulting firm in the next few days, in order to verify its usability in impairment testing. As a result, the Board of Directors decided to defer approval of impairment testing and the financial statements for 2022.


Leave a Reply

Your email address will not be published. Required fields are marked *